Pfizer Recalls Blood Pressure Drug That Contains Potential Carcinogen
Pfizer is voluntarily recalling some lots of its blood pressure pill Accuretic that have elevated levels of nitrosamine, an impurity that can increase the risk of cancer.
The company said in a statement that it is recalling six lots of brand-name Accuretic tablets with nitrosamine levels above the acceptable daily intake, along with several lots of generic versions of this blood pressure drug.
Retiree News 
Comments are closed.